Orphan Drug Designation for Galactosemia Therapy - P&T Community

Orphan Drug Designation for Galactosemia Therapy  P&T Community

Applied Therapeutics Inc. has received an orphan drug designation for AT-007, a central nervous system (CNS) penetrant Aldose Reductase inhibitor (ARI) in ...